Company Valuation: ResMed, Inc.

Data adjusted to current consolidation scope
Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Capitalization 1 35,903 30,691 32,133 28,117 37,762 39,571 - -
Change - -14.52% 4.7% -12.5% 34.31% 4.79% - -
Enterprise Value (EV) 1 36,263 31,192 33,346 28,585 37,221 38,505 37,698 36,652
Change - -13.98% 6.9% -14.28% 30.21% 3.45% -2.1% -2.77%
P/E ratio 76.1x 39.6x 35.9x 27.7x 27.1x 25.7x 23x 21x
PBR 12.4x 9.35x 7.76x 5.78x 6.33x 5.8x 5.09x 4.72x
PEG - 0.6x 2.4x 2x 0.7x 2.3x 2x 2.25x
Capitalization / Revenue 11.2x 8.58x 7.61x 6x 7.34x 7.01x 6.52x 6.09x
EV / Revenue 11.3x 8.72x 7.9x 6.1x 7.23x 6.82x 6.21x 5.64x
EV / EBITDA 33.8x 26.8x 25.3x 18.1x 19.8x 17.5x 15.9x 14.2x
EV / EBIT 40.1x 31.2x 27.2x 19.3x 21.1x 18.8x 16.8x 15.1x
EV / FCF 57.2x 144x 58.1x 22x 22.4x 25.3x 22.5x 20.4x
FCF Yield 1.75% 0.69% 1.72% 4.55% 4.46% 3.95% 4.44% 4.91%
Dividend per Share 2 1.56 1.68 1.8 1.92 2.12 2.434 2.696 2.635
Rate of return 0.63% 0.8% 0.82% 1% 0.82% 0.9% 0.99% 0.97%
EPS 2 3.24 5.3 6.09 6.92 9.51 10.59 11.81 12.92
Distribution rate 48.1% 31.7% 29.6% 27.7% 22.3% 23% 22.8% 20.4%
Net sales 1 3,197 3,578 4,223 4,685 5,146 5,645 6,069 6,494
EBITDA 1 1,074 1,162 1,317 1,576 1,884 2,198 2,368 2,576
EBIT 1 903.7 1,000 1,224 1,478 1,763 2,050 2,239 2,422
Net income 1 474.5 779.4 897.6 1,021 1,401 1,547 1,726 1,885
Net Debt 1 360.1 501.5 1,213 468.9 -541.2 -1,066 -1,873 -2,918
Reference price 2 246.52 209.63 218.50 191.42 258.00 271.63 271.63 271.63
Nbr of stocks (in thousands) 1,45,640 1,46,405 1,47,062 1,46,884 1,46,365 1,45,678 - -
Announcement Date 05/08/21 11/08/22 03/08/23 01/08/24 31/07/25 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
25.66x6.82x17.52x0.9% 3.96TCr
30.39x5.25x20.75x0.31% 20TCr
55.25x14.3x33.4x-.--% 17TCr
41.55x6.79x22.01x0.58% 15TCr
37.41x6.07x19.81x-.--% 11TCr
20.46x2.36x11.61x2.56% 5.46TCr
34.77x6.99x23.13x-.--% 4.57TCr
16.94x1.9x10.28x0.19% 3.68TCr
24.3x5.1x17.76x0.79% 3.67TCr
23.93x6.12x17.36x2.76% 3.3TCr
Average 31.07x 6.17x 19.36x 0.81% 8.9TCr
Weighted average by Cap. 36.41x 7.25x 22.05x 0.51%
See all sector valuations

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Valuation ResMed, Inc.